Ann: Appendix 4C - quarterly, page-35

I hope the share price keeps on going lower so I can buy add more shares to my current shareholding. This company is going to be fine. One should think of Zoono as a platform from which various medical/biological applications can be derived. It's a micro-cap company. As such, investing in it right at this stage carries significant risk. I am steadily investing in this company with a three to five year outlook. As long as the company is keeping the lid on cash burn while gradually increasing revenue, I will remain a happy investor.

GLTUA!